Plus Therapeutics Inc (PSTV)
1.55
-0.08
(-4.91%)
USD |
NASDAQ |
Apr 24, 16:00
1.55
0.00 (0.00%)
After-Hours: 19:03
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 6.750M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -58.84% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 0.7768 |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 99.98% |
Profile
| Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focuses on the discovery, development, and delivery of complex treatments for patients battling cancer and rare diseases. Its product pipeline includes Patented RNL and Patented DocePLUS. |
| URL | https://www.plustherapeutics.com |
| Investor Relations URL | http://ir.cytori.com/investor-relations/default.aspx |
| HQ State/Province | Texas |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | Jul. 22, 2021 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focuses on the discovery, development, and delivery of complex treatments for patients battling cancer and rare diseases. Its product pipeline includes Patented RNL and Patented DocePLUS. |
| URL | https://www.plustherapeutics.com |
| Investor Relations URL | http://ir.cytori.com/investor-relations/default.aspx |
| HQ State/Province | Texas |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | Jul. 22, 2021 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |